Philip Gianos Insider Sell Transaction
Philip Gianos, the shareholder of Xilinx, Inc. (NASDAQ:XLNX)
Xilinx Inc Stock Rating, Sentiment and Fundamentals
Stats from the twenty six professional security analysts who cover Xilinx Inc’s stock forecast the PE ratio to be 24.13 if the EPS in 2015 is $2.03 per share. Thus, the YOY growth rate is expected to be not more than 10.33%.
|Rating & Sentiment|
|Hedge Funds Sentiment:||NEUTRAL|
|Earnings + FCF Trend:||BUY|
* Read How Our Stock Ratings System Works
In accordance with our research and trend model, we rate the -listed company as Neutral. Take a look at the chart below. Within the last 200 days, Xilinx Inc’s price per share has climbed 26.85 % and shows a strong and smooth bullish uptrend.
Price Chart of Xilinx NASDAQ:XLNX Stock
Source: RightEdgeSystems, Yahoo Split & Dividend Adjusted Data and OctaFinance Interpretations
Legendary speculators such as John Burbank have often claimed that the highest returns are made through technical and fundamental analysis. This is definitely not the case with Xilinx Inc. The information is as shown in a SEC filing dated 19/11/2015.
Hedge Funds Ownership
Recently released 13F public filings data reveal 474 investment managers own shares of Xilinx Inc. In Q2 2015, Xilinx Inc had 89.90 % institutional ownership. That is a very high interest. They decreased by 1.97 million the total shares they hold. As of that quarter these hedge funds owned 232.54 million shares. A total of 73 funds opened new positions in Xilinx Inc and 141 increased their holdings. There were 39 funds that closed their positions and 202 that reduced them.
The company is Top 10 in six of them. These are: Omers Administration Corp, Ashmore Wealth Management Llc, Oak Associates Ltd Oh, Santa Fe Partners Llc, Blue Harbour Group L.P., Morgens Waterfall Vintiadis & Co Inc.
Omers Administration Corp had the greatest investment with ownership of 1.12 million shares as of Q2 2015 for 1.97% of the fund’s portfolio. Ashmore Wealth Management Llc is another bullish player owning 5.50 million shares of the company or 5.32% of their stocks portfolio. The Ohio-based fund Oak Associates Ltd Oh have 2.95% of their stock portfolio invested in the company’s market cap for 548,665 shares. In addition, The New Mexico-based fund Santa Fe Partners Llc revealed it had purchased a stake worth 0.51% of the fund’s stock portfolio in the company. Clifton S. Robbins’s Blue Harbour Group L.P. was also a notable supporter of the firm, with ownership of 3.28 million shares. Xilinx Inc is 4.23% of the fund’s stock portfolio.
Xilinx NASDAQ:XLNX Company Profile
Xilinx, Inc. (Xilinx) designs and develops programmable devices and associated technologies. The Company’s programmable devices and associated technologies include integrated circuits (IC) in the form of programmable logic devices (PLD); software design tools to program the PLDs; targeted reference designs; printed circuit boards, and intellectual property (IP), which consists of Xilinx, and third-party verification and IP cores. The Company provides design services, customer training, field engineering and technical support. Its PLDs include field programmable gate arrays (FPGAs), complex programmable logic devices (CPLDs), programmable System on Chips (SoCs) and three-dimensional ICs (3D ICs). Its product portfolio is designed to provide integration for electronic equipment manufacturers in end markets, such as wired and wireless communications, industrial, scientific and medical, aerospace and defense, audio, video and broadcast, consumer, automotive, and test and measurement.
Company Website: Xilinx
Xilinx Inc was founded in Delaware on 1990-02-05. This company has 3451 employees. Currently its market cap is: $12.58 billion and it has 257.15 million outstanding shares. Currently there are 92.46% shareholders and the institutional ownership stands at 92.46%. The stock closed at $48.939999 yesterday and it had average 2 days volume of 576521 shares. It is down from the 30 days average shares volume of 938558. Xilinx Inc has a one year low of $37.20 and a 250 days high of $49.40. The current price is above the 200 days Simple moving average. Xilinx Inc last issued its quarterly earnings information on 10/14/2015. The company reported 0.48 EPS for the quarter, above the consensus estimate of 0.46 by 0.02. The company had a revenue of 527.57 million for 9/26/2015 and 549.01 million for 6/27/2015. Therefore, the revenue was -21,436,000 down.
Philip Gianos is also director of T/R Systems Inc, 10 percent owner of Glaukos Corp, Invuity, Inc., Carbylan Therapeutics, Inc., Marketo, Inc., Applied Genetic Technologies Corp, Macrogenics Inc, Paratek Pharmaceuticals, Inc., Metabasis Therapeutics Inc, Anesiva, Inc., Enteromedics Inc, Myogen Inc, Intralase Corp.
* All shares sold at $46.6537
Xilinx - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.